Home/Filings/4/0000899243-20-018606
4//SEC Filing

Baltic Charles V. III 4

Accession 0000899243-20-018606

CIK 0001262104other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 12:54 PM ET

Size

11.5 KB

Accession

0000899243-20-018606

Insider Transaction Report

Form 4
Period: 2020-07-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-07-02+50,00050,000 total
    Exercise: $3.49Exp: 2030-07-02Common Stock (50,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    Exercise: $1.57Exp: 2025-07-28Common Stock (20,000 underlying)
    20,000
  • Stock Option (Right to Buy)

    Exercise: $1.36Exp: 2026-07-29Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    Exercise: $2.83Exp: 2027-07-06Common Stock (40,000 underlying)
    40,000
Footnotes (2)
  • [F1]The options will vest in equal monthly installments over twelve months.
  • [F2]All of such options are presently exercisable.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001533340

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 12:54 PM ET
Size
11.5 KB